Antipsychotic drugs, dopamine receptors, and schizophrenia
- 1 January 2001
- journal article
- Published by Elsevier in Clinical Neuroscience Research
- Vol. 1 (1-2) , 53-60
- https://doi.org/10.1016/s1566-2772(00)00007-4
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Resistance of the Dopamine D2L Receptor to Desensitization Accompanies the Up-Regulation of Receptors on to the Surface of Sf9 CellsEndocrinology, 1997
- Clozapine occupies high levels of dopamine D2 receptorsLife Sciences, 1997
- The D2 Receptor Occupancy Profile of Loxapine Determined Using PETNeuropsychopharmacology, 1996
- Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligandEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A pet studyLife Sciences, 1995
- Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infectionJournal of Psychopharmacology, 1995
- A long‐term study of remoxipride in chronic schizophrenic patientsActa Psychiatrica Scandinavica, 1993
- Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidolJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levelsPsychopharmacology, 1989
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976